Notice of Annual General Meeting/Proxy Form
Released
Released
Announcement PDF
Biome Australia Limited
ACN 627 364 014
Notice of Annual General Meeting
To be held at: 192-194 Johnston Street, Collingwood VIC 3066 and online via weblink
To be held on: Tuesday 29 November 2022
Commencing: 10am AEDST (Melbourne time)
Important Information
The Company is pleased to provide Shareholders with the opportunity to attend and participate in the Meeting virtually,
through an online meeting platform where Shareholders will be able to participate and vote online.
Click here to register
Details on how to access the Meeting virtually are set out in this Notice.
This Notice of Annual General Meeting should be read in its entirety. If Shareholders are in doubt as to how they should
vote, they should seek advice from their professional advisors prior to voting.
Biome Australia Limited – Notice of 2022 Annual General Meeting
TIME AND PLACE OF MEETING
Notice is hereby given that the 2022 Annual General Meeting of Biome Australia Limited (ACN 627 364 014) (the Company)
will be held on Tuesday 29 November 2022, commencing at 10:00am AEDST.
The meeting will be held in person at 192-194 Johnston Street, Collingwood, Victoria 3066, and also online through a virtual
weblink where Shareholders will be able to watch, listen and vote.
VOTING BY PROXY
To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the
instructions set out on the Proxy Form.
In accordance with section 249L of the Corporations Act, Shareholders are advised that:
•
each Shareholder has a right to appoint a proxy;
•
the proxy need not be a Shareholder of the Company; and
•
a Shareholder who is entitled to cast two (2) or more votes may appoint two (2) proxies and may specify the proportion
or number of votes each proxy is appointed to exercise. If the member appoints two (2) proxies and the appointment
does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the
Corporations Act , each proxy may exercise one-half of the votes.
Shareholders and their proxies should be aware that:
•
if proxy holders vote, they must cast all directed proxies as directed; and
•
any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed.
VOTING IN PERSON
The Company is looking forward to including a normal physical meeting format, as well as retaining the online option via
weblink, for the 2022 AGM.
If it becomes necessary or appropriate to make alternative arrangements for the meeting, we will provide further information
on the Company’s website https://biomeaustralia.com/ and via an ASX announcement.
You must lodge your vote or proxy in advance of the meeting by 10:00am (AEDST) on Sunday 27 November 2022. If you have
lodged a proxy, you are still entitled to attend the Meeting either in person or by weblink.
You must register your interest to attend the meeting by weblink on or before 10:00 am (AEDST Sunday 27 November 2022
by registering at Click here to register.
VIRTUAL MEETING
If you wish to virtually attend the Meeting (which will be broadcast as a live webinar), you will be sent a Meeting ID & Shareholder
ID in advance for the virtual Meeting provided that you register here:
Click here to register
Shareholders will be able to vote and ask questions at the virtual Meeting. Shareholders are also encouraged to submit
questions in advance of the Meeting to the Company. Questions must be submitted in writing to George Lazarou, Company
Secretary at george@activated.co at least 48 hours before the Meeting.
The Company will also provide Shareholders with the opportunity to ask questions during the Meeting in respect to the formal
items of business as well as general questions in respect to the Company and its business.
Voting virtually
Shareholders who wish to vote virtually on the day of the Meeting will need to register by weblink Click here to register.
All resolutions will be by poll
Votes on each of the resolutions proposed at the AGM will be conducted by way of a poll.
Eligibility to vote
The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations that the persons eligible to vote
at the Annual General Meeting are those that are registered Shareholders at 7:00 p.m. AEDST on Sunday, 27 November 2022.
If you are not the registered holder of a relevant Share at that time you will not be entitled to vote in respect of that Share.
Should you wish to discuss the matters in this Notice of Meeting please do not hesitate to contact the Company
Secretary on (03) 8617 8014.
ITEMS OF BUSINESS
1.
FINANCIAL STATEMENTS AND REPORTS
To receive and consider the annual financial report of the Company for the financial period ended 30 June 2022
together with the declaration of the Directors, the Directors’ Report, the Remuneration Report and the Auditor’s
Report.
2.
RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary
resolution:
“That, for the purpose of Section 250R(2) of the Corporations Act and for all other purposes,
approval is given for the adoption of the Remuneration Report, as contained in the Company’s
annual financial report for the financial year ended 30 June 2022.”
Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company.
A vote on this Resolution must not be cast (in any capacity) by or on behalf of either of the following persons:
(a) a member of the Key Management Personnel, details of whose remuneration are included in the
Remuneration Report; or
(b) a Closely Related Party of such a member.
However, a person (the voter) described above may cast a vote on this Resolution as a proxy if the vote is not
cast on behalf of a person described above and either:
(a) the voter is appointed as a proxy by writing that specifies the way the proxy is to vote on this
Resolution; or
(b) the voter is the Chair and the appointment of the Chair as proxy:
(i) does not specify the way the proxy is to vote on this Resolution; and
(ii) expressly authorises the Chair to exercise the proxy even though this Resolution is connected
directly or indirectly with the remuneration of a member of the Key Management Personnel.
3.
RESOLUTION 2 – RE-ELECTION OF DIRECTOR – MS DOMINIQUE FISHER
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary
resolution:
“That, for the purpose of ASX Listing Rule 14.5 and for all other purposes, Ms Dominique Fisher, a
Director, retires by rotation, and being eligible, is re-elected as a Director.”
4.
RESOLUTION 3 – APPROVAL OF NON-EXECUTIVE DIRECTORS' FEE POOL
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary
resolution:
"That, for the purposes of rule 18.10(a) of the Company’s Constitution and for all other purposes,
approval is given to set the maximum total aggregate remuneration per annum that the Company’s
non-executive Directors are entitled to be paid for their services as Directors to $400,000 (inclusive
of superannuation) per annum."
The Company will disregard any votes cast in favour of this Resolution by or on behalf of any Director or
any associate of a Director.
However, this does not apply to a vote cast in favour of this Resolution by:
(a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with the directions given to the proxy or attorney to vote on the Resolution in that
way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides;
or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not
excluded from voting, and is not an associate of a person excluded from voting, on the
resolution; and
(ii)
the holder votes on the resolution in accordance with directions given by the beneficiary
to the holder to vote in that way.
In addition, in accordance with section 250BD of the Corporations Act, a person appointed as a proxy must
not vote on the basis of that appointment, on this Resolution if:
(a) the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(b) the appointment does not specify the way the proxy is to vote on this Resolution.
However, the above prohibition does not apply if:
(a) the proxy is the Chair; and
(b) the appointment expressly authorises the Chair to exercise the proxy even though this
Resolution is connected directly or indirectly with remuneration of a member of the Key
Management Personnel.
5.
RESOLUTION 4 - REPLACEMENT OF CONSTITUTION
To consider and, if thought fit, to pass the following resolution as a special resolution:
“That, for the purposes of section 136(2) of the Corporations Act and for all other purposes, approval
is given for the Company’s Constitution be amended as set out in the Explanatory Statement, with
effect from the end of the Meeting.”
6.
RESOLUTION 5 – APPROVAL OF 7.1A MANDATE
To consider and, if thought fit, to pass the following resolution as a special resolution:
“That, for the purposes of ASX Listing Rule 7.1A and for all other purposes, approval is given for
the issue of equity securities totalling up to 10% of the issued capital of the Company at the time of
issue, calculated in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 and
otherwise on the terms and conditions set out in the Explanatory Statement accompanying this
Notice of Meeting.”
The accompanying important information and Explanatory Memorandum form part of this Notice of Annual General
Meeting.
By order of the Board
George Lazarou
Company Secretary
12 October 2022
EXPLANATORY STATEMENT
1.
ITEM 1: FINANCIAL STATEMENTS AND REPORTS
1.1
Purpose of Resolution
In accordance with the Constitution, the business of the Meeting will include receipt and consideration of
the annual financial report of the Company for the financial year ended 30 June 2022 together with the
declaration of the Directors, the Directors’ Report, the Remuneration Report and the Auditor’s Report.
The Company will not provide a hard copy of the Company’s annual financial report to Shareholders unless
a Shareholder has previously elected to receive one pursuant to section 314 of the Corporations Act. The
Company’s annual financial report is available on its website at https://biomeaustralia.com.
1.2
Questions to the Chair
Shareholders will be given reasonable opportunity at the meeting to raise questions and make comments
on the Company’s annual financial report.
In addition to asking questions at the meeting, Shareholders may address written questions to the Chair
about the management of the Company or to the Company’s auditor, JTP Assurance, if the question is
relevant to:
•
the content of the Auditor’s Report; or
•
the conduct of its audit of the Financial Report to be considered at the Annual General Meeting.
Note: Under section 250PA(1) Corporations Act a shareholder must submit the question to the Company
no later than the fifth business day before the day on which the Annual General Meeting is held.
Written questions for the Company's auditor must be delivered by 5:00 p.m. AEDST on 20 November 2022
to:
The Company Secretary
George Lazarou
Email: george@activated.co
2.
ITEM 2: RESOLUTION 1 - ADOPTION OF REMUNERATION REPORT
2.1
General
The Corporations Act requires that at a listed company’s annual general meeting, a resolution that the
remuneration report be adopted must be put to the shareholders. However, such a resolution is advisory
only and does not bind the directors or the company.
The Remuneration Report sets out the Company’s remuneration arrangements for the Directors and senior
management of the Company. The Remuneration Report is part of the Directors’ Report contained in the
annual financial report of the Company for the financial year ending 30 June 2022.
The chair of the meeting must allow a reasonable opportunity for its shareholders to ask questions about
or make comments on the remuneration report at the annual general meeting.
2.2
Voting consequences
A company is required to put to its shareholders a resolution proposing the calling of another meeting of
shareholders to consider the appointment of directors of the company (Spill Resolution) if, at consecutive
annual general meetings, at least 25% of the votes cast on a remuneration report resolution are voted
against adoption of the remuneration report and at the first of those annual general meetings a Spill
Resolution was not put to vote. If required, the Spill Resolution must be put to vote at the second of those
annual general meetings.
If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a
shareholder meeting (Spill Meeting) within 90 days of the second annual general meeting.
All of the directors of the company who were in office when the directors' report (as included in the
company’s annual financial report for the previous financial year) was approved, other than the managing
director of the company, will cease to hold office immediately before the end of the Spill Meeting but may
stand for re-election at the Spill Meeting.
Following the Spill Meeting those persons whose election or re-election as directors of the company is
approved will be the directors of the company.
2.3
Previous voting results
At the Company’s previous annual general meeting, the votes cast against the remuneration report
considered at that annual general meeting were less than 25%. Accordingly, the Spill Resolution is not
relevant for this Annual General Meeting.
2.4
Voting exclusion and Directors’ recommendation
As set out in the notes to Resolution 1, a voting exclusion statement applies with respect to the voting on
this Resolution by certain persons connected to the Company.
As the resolution relates to matters including the remuneration of the Directors, the Board, as a matter of
corporate governance, makes no recommendation regarding this Resolution.
The Chair of the Annual General Meeting intends to vote undirected proxies in favour of Resolution 1,
subject to compliance with the Corporations Act.
3.
ITEM 3: RESOLUTION 2 – RE-ELECTION OF DIRECTOR – MS DOMINIQUE FISHER
3.1
General
Listing Rule 14.4 and clause 18.5(b) of the Constitution provide that, other than a managing director, a
director of an entity must not hold office (without re-election) past the third annual general meeting
following the director’s appointment or 3 years, whichever is the longer. However, where there is more
than one managing director, only one is entitled to be exempt from this rotation requirement. This applies
from the time of admission.
ASX Listing Rule 14.5 provides that an entity which has directors must hold an election of directors at each
annual general meeting.
Ms Dominique Fisher was appointed on 12 August 2021 and stands for re-election under ASX Listing Rule
14.5.
3.2
Qualifications and other material directorships
Ms Fisher couples her experience in tech-driven businesses with a strong focus on risk mitigation and
financial management which has led to her working across a wide range of sectors in both executive and
non-executive roles. Ms Fisher has an extensive non-executive career, having served on ASX listed
companies IAG, Circadian Technologies/ Opthea, Pacific Brands and GrowthOps (2 as Chair), including
two IPOs (IAG and TGO) and numerous unlisted companies, including NRMA, LaunchVic and
SkyTechnologies.
Ms Fisher has extensive Audit, Remuneration and Risk Committee experience of listed and unlisted
companies. Ms Fisher has also served on various government and private advisory boards at both state
and federal for both major political parties and government agencies, including the Sydney Opera House,
Australia Post and the Australian Council for the Arts.
Independence
The Company considers Ms Fisher to be independent on the basis she has no interests, position,
association or relationship that might influence, or reasonably be perceived to influence, in a material
respect her capacity to bring an independent judgement to bear on issues before the Board and to act in
the best interest of the Company as a whole rather than in the interests of an individual security holder or
other party.
If re-elected, the Board considers Ms Fisher will be an independent director.
3.3
Directors’ recommendation
The Board, with Ms Fisher not being present while the matter was considered and abstaining from voting,
consider that Ms Fisher has made and will continue to make a valuation contribution to the Board and the
Company, and recommend that Shareholders vote in favour of the re-election of Ms Fisher.
The Chair intends to vote undirected proxies in favour of Resolution 2.
4.
ITEM 4: RESOLUTION 3 - APPROVAL OF NON-EXECUTIVE DIRECTORS' FEE POOL
4.1
General
The Company is currently operating with three Directors, however, as the Company grows there will likely
be the need for additional non-executive and independent Directors of the Company to be appointed to
the Board. Accordingly, the number of Directors will likely increase and, having regard to clause 18.10(a)
of the Constitution, the Board considers Shareholders should be given the opportunity to approve the total
aggregate non-executive Directors’ fee pool.
If Resolution 3 is passed, the maximum total aggregate remuneration payable by the Company to nonexecutive Directors will be set at $400,000 (inclusive of superannuation) per annum (NED Fee Pool). This
amount has been determined after reviewing corporate remuneration of similar companies listed on ASX
and the Directors believe that this level of remuneration is in line with market.
If Resolution 3 is passed, it is not envisaged that the proposed NED Fee Pool will be utilised immediately,
or in the short to medium term.
It is further noted that, if the Company is looking to increase the NED Fee Pool in the future, Listing Rule
10.17 provides entities must not increase the total aggregate non-executive directors' fee pool without the
prior approval of Shareholders.
Shareholder approval of the NED Fee Pool is sought to ensure that the Company:
(a)
(b)
(c)
4.2
has the ability to attract and retain new high calibre non-executive Directors whose skills
and qualifications are appropriate for a company of the size and nature of the Company;
maintains its capacity to remunerate both existing and any new non-executive Directors
joining the Board; and
remunerates its non-executive Directors appropriately for the expectations placed upon
them both by the Company and the regulatory environment in which it operates.
No Directors’ recommendation
As set out in the notes to Resolution 3, a voting exclusion statement applies with respect to the voting on
this Resolution by certain persons connected to the Company.
Given the personal interests of non-executive Directors in the outcome of Resolution 3, the Directors make
no recommendation in relation to Resolution 3.
5.
ITEM 5: RESOLUTION 4 - REPLACEMENT OF CONSTITUTION
5.1
General
A company may modify or repeal its constitution or a provision of its constitution by special resolution of
its shareholders.
Resolution 4 is a special resolution which will enable the Company to amend its existing Constitution to
take into account recent changes to the Corporations Act regarding virtual and hybrid meetings.
A copy of the existing Constitution is available at Constitution. A marked-up version of the proposed
amended Constitution is available at Amended Constitution (Amended Constitution). A marked-up copy
of the Amended Constitution can also be sent to Shareholders upon request by contacting the Company
Secretary at +61 3 8617 8014.
A summary of the proposed material changes is set out in section 5.2 below.
For Resolution 4 to be passed as a special resolution, at least 75% of the votes cast by Shareholders
entitled to vote must be in favour of the Resolution. If Resolution 4 is passed, the amendments in the
marked-up copy of the Amended Constitution will be adopted. If Resolution 4 is not passed, the
amendments will not apply going forward.
5.2
Summary of material proposed change
Use of Technology at General Meetings (new clause 15.1 and 15.2)
The Amended Constitution includes new provisions which allow the Company, to the extent permitted
under the Corporations Act, ASX Listing Rules and any other applicable law, to convene a general meeting
using virtual technology only, or at two or more venues, provided that the form of technology used provides
all shareholders entitled to attend the meeting, as a whole, a reasonable opportunity to participate in the
meeting without being physically present in the same place.
These new provisions reflect recent amendments made to the Corporations Act by the Corporations
Amendment (Meetings and Documents) Act 2022 (Cth) (Corporations Amendment Meetings and
Documents Act). One of these amendments provides that a company may hold a meeting of its members
using virtual meeting technology only if this is required or permitted by the company’s constitution. The
new provision contains this permission.
Where a general meeting is held using virtual technology only or at two or more venues using any form of
technology:
(a)
a Shareholder participating in the meeting is taken to be present in person at the meeting;
(b)
any documents required or permitted to be tabled at the meeting will be taken to have been tabled
at the meeting if the document is given, or made available, to the persons entitled to attend the
meeting (whether physically or using technology) before or during the meeting; and
(c)
the meeting is taken to be held at the physical venue set out in the notice of meeting, or at the
registered office of the Company if the meeting is held using virtual technology only.
To the extent permitted under the Corporations Act, ASX Listing Rules and any other applicable law, any
document that is required or permitted to be given to a Shareholder that relates to a Shareholders’ meeting
(including, but not limited to, the notice of meeting) may be distributed:
(a)
by means of electronic communication; or
(b)
by giving the Shareholder (by means of an electronic communication or otherwise) sufficient
information to allow the person to access the document electronically,
in accordance with the Corporations Act. This also reflects the recent amendments made by the
Corporations Amendment Meetings and Documents Act.
Other changes to facilitate the use of technology have also been made to clauses 1.2 (Interpretation) and
30 (Notices and services).
5.3
Directors’ recommendation
The Board unanimously recommends that Shareholders vote in favour of Resolution 4 to adopt the
Amended Constitution.
6.
ITEM 6: RESOLUTION 5 – APPROVAL OF 7.1A MANDATE
6.1
General
ASX Listing Rule 7.1 limits the amount of Equity Securities that a listed company can issue without the
approval of its shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on
issue at the start of that period.
However, under Listing Rule 7.1A, an eligible entity may seek shareholder approval by way of a special
resolution passed at its annual general meeting to increase this 15% limit by an extra 10% to 25% (7.1A
Mandate).
An ‘eligible entity’ means an entity which is not included in the S&P/ASX 300 Index and has a market
capitalisation of $300,000,000 or less. The Company is an eligible entity for these purposes.
As at the date of this Notice, the Company is an eligible entity as it is not included in the S&P/ASX 300
Index and has a current market capitalisation of $14,993,239 (based on the number of Shares on issue
and the closing price of Shares on the ASX on 12 October 2022).
Resolution 5 seeks Shareholder approval by way of special resolution for the Company to have the
additional 10% placement capacity provided for in Listing Rule 7.1A to issue Equity Securities without
Shareholder approval. For Resolution 5 to be passed as a special resolution, at least 75% of the votes
cast by Shareholders entitled to vote must be in favour of the Resolution.
If Resolution 5 is passed, the Company will be able to issue Equity Securities up to the combined 25%
limit in Listing Rules 7.1 and 7.1A without any further Shareholder approval.
If Resolution 5 is not passed, the Company will not be able to access the additional 10% capacity to issue
Equity Securities without Shareholder approval under Listing Rule 7.1A and will remain subject to the 15%
limit on issuing Equity Securities without Shareholder approval set out in Listing Rule 7.1.
6.2
Technical information required by ASX Listing Rule 7.1A
Pursuant to and in accordance with ASX Listing Rule 7.3A, the information below is provided in relation to
Resolution 5:
(a)
Period for which the 7.1A Mandate is valid
The 7.1A Mandate will commence on the date of the Meeting and expire on the first to occur of the
following:
(i)
the date that is 12 months after the date of this Meeting;
(ii)
the time and date of the Company’s next annual general meeting; and
(iii)
(b)
the time and date of approval by Shareholders of any transaction under Listing Rule 11.1.2
(a significant change in the nature or scale of activities) or Listing Rule 11.2 (disposal of the
main undertaking).
Minimum price
Any Equity Securities issued under the 7.1A Mandate must be in an existing quoted class of Equity
Securities and be issued at a minimum price of 75% of the volume weighted average price of Equity
Securities in that class, calculated over the 15 trading days on which trades in that class were recorded
immediately before:
(c)
(i)
the date on which the price at which the Equity Securities are to be issued is agreed by the
entity and the recipient of the Equity Securities; or
(ii)
if the Equity Securities are not issued within 10 trading days of the date in Section 6.2(b)(i),
the date on which the Equity Securities are issued.
Use of funds raised under the 7.1A Mandate
The Company intends to use funds raised from issues of Equity Securities under the 7.1A Mandate to
provide further funding, if required, for assessment of future opportunities, ongoing administration and
corporate costs, general working capital and/or for the acquisition of new businesses, assets or other
investments.
(d)
Risk of economic and voting dilution
Any issue of Equity Securities under the 7.1A Mandate will dilute the interests of Shareholders who do not
receive any Shares under the issue.
If Resolution 5 is approved by Shareholders and the Company issues the maximum number of Equity
Securities available under the 7.1A Mandate, the economic and voting dilution of existing Shares would
be as shown in the table below.
The table below shows the dilution of existing Shareholders calculated in accordance with the formula
outlined in Listing Rule 7.1A.2, on the basis of the closing market price of Shares and the number of Equity
Securities on issue as at 12 October 2022.
The table also shows the voting dilution impact where the number of Shares on issue (Variable A in the
formula) changes and the economic dilution where there are changes in the issue price of Shares issued
under the 7.1A Mandate.
Dilution
Issue Price
Number of Shares on Issue
(Variable A in Listing Rule
7.1A.2)
Shares
issued –
10% voting
dilution
$0.0375
$0.075
$0.1125
50%
decrease
Issue Price
50%
increase
Funds Raised
Current
199,909,857
Shares
19,990,985
Shares
$749,662
$1,499,324
$2,248,986
50%
increase
299,864,785
Shares
29,986,478
Shares
$1,124,493
$2,248,986
$3,373,479
100%
increase
399,819,714
Shares
39,981,971
Shares
$1,499,324
$2,998,648
$4,497,972
*The number of Shares on issue (Variable A in the formula) could increase as a result of the issue of Shares that do not require
Shareholder approval (such as under a pro-rata rights issue or scrip issued under a takeover offer) or that are issued with
Shareholder approval under Listing Rule 7.1.
The table above uses the following assumptions:
1.
There are currently 199,909,857 Shares on issue.
2.
The issue price set out above is the closing market price of the Shares on the ASX on 12 October 2022.
3.
The Company issues the maximum possible number of Equity Securities under the 7.1A Mandate.
4.
The Company has not issued any Equity Securities in the 12 months prior to the Meeting that were not
issued under an exception in Listing Rule 7.2 or with approval under Listing Rule 7.1.
5.
The issue of Equity Securities under the 7.1A Mandate consists only of Shares. It is assumed that no
Options or other convertible securities are exercised into Shares before the date of issue of the Equity
Securities.
6.
The calculations above do not show the dilution that any one particular Shareholder will be subject to.
All Shareholders should consider the dilution caused to their own shareholding depending on their
specific circumstances.
7.
This table does not set out any dilution pursuant to approvals under Listing Rule 7.1 unless otherwise
disclosed.
8.
The 10% voting dilution reflects the aggregate percentage dilution against the issued share capital at the
time of issue. This is why the voting dilution is shown in each example as 10%.
9.
The table does not show an example of dilution that may be caused to a particular Shareholder by reason
of placements under the 7.1A mandate, based on that Shareholder’s holding at the date of the Meeting.
Shareholders should note that there is a risk that:
(e)
(i)
the market price for the Compa
Share your feedback
Discover